# Viet Nam Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Viet Nam HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Viet Nam (VNM)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $959.1M
- Products: 38
- Buyer markets: 28
- Average CAGR: +36.2%
- Global sector size: $634.5B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $306.0B | $72.6M | $115.1B | +19.3% | 21 | +0.0% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $110.8B | $860.7K | $41.2B | +88.3% | 5 | +0.0% |
| HS 300220 - Vaccines: for human medicine | $21.4B | $17.1K | $18.0B | -4.9% | 4 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $23.1B | $299.0M | $16.7B | +25.1% | 8 | +1.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $28.9B | $1.1M | $16.1B | +82.2% | 6 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $16.7B | $444.8K | $12.4B | +25.8% | 7 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $7.9B | $13.9K | $10.7B | +25.8% | 3 | +0.0% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $11.9B | $60.2K | $7.4B | +67.5% | 2 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $16.8B | $11.8M | $6.9B | +15.1% | 3 | +0.1% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $15.1B | $10.9M | $6.3B | +44.0% | 3 | +0.1% |
| HS 290243 - Cyclic hydrocarbons: p-xylene | $8.5B | $352.2M | $5.7B | +5.6% | 1 | +4.1% |
| HS 284190 - Salts of oxometallic or peroxometallic acids: n.e.c. in heading no. 2841 | $3.3B | $4.3M | $5.6B | +181.0% | 2 | +0.2% |
| HS 282200 - Cobalt oxides and hydroxides: commercial cobalt oxides | $2.4B | $2.4K | $4.6B | +31.7% | 1 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $6.6B | $4.3M | $4.1B | +25.9% | 2 | +0.0% |
| HS 290220 - Cyclic hydrocarbons: benzene | $4.1B | $97.9M | $3.3B | +12.0% | 1 | +2.4% |
| HS 381800 - Chemical elements: doped for use in electronics, in the form of discs, wafers or similar forms: chemical compounds doped for use in electronics | $5.7B | $48.7M | $3.2B | +54.7% | 2 | +0.9% |
| HS 293590 - Sulphonamides: n.e.c. in heading no. 2935 | $1.6B | $12.7 | $3.1B | -26.9% | 1 | +0.0% |
| HS 281820 - Aluminium oxide: other than artificial corundum | $4.6B | $249.4 | $2.9B | -42.6% | 2 | +0.0% |
| HS 290110 - Acyclic hydrocarbons: saturated | $1.5B | $651.4 | $2.4B | -26.4% | 2 | +0.0% |
| HS 285390 - Phosphides, chemically defined or not, not ferrophosphorus: other inorganic compounds n.e.c. (including distilled, conductivity water and water of like purity): liquid air, rare gases removed or not: compressed air: amalgams, not precious metal amalgams | $1.3B | $273.7 | $2.4B | +6.8% | 1 | +0.0% |
| HS 282590 - Inorganic bases, metal oxides, hydroxides and peroxides: n.e.s. in heading no. 2825 | $1.5B | $18.1M | $2.3B | +18.4% | 1 | +1.2% |
| HS 382600 - Biodiesel and mixtures thereof: not containing or containing less than 70% by weight of petroleum oils or oils obtained from bituminous minerals | $2.0B | $94.5K | $2.3B | +33.3% | 1 | +0.0% |
| HS 290531 - Alcohols: acyclic, diols: ethylene glycol (ethanediol) | $3.2B | $462.8K | $2.2B | +213.5% | 1 | +0.0% |
| HS 381512 - Catalysts, supported: reaction initiators, reaction accelerators and catalytic preparations, with precious metal or precious metal compounds as the active substance, n.e.c. or included | $3.1B | $17.3K | $2.1B | +39.4% | 1 | +0.0% |
| HS 300420 - Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $3.8B | $10.4K | $2.0B | -10.3% | 1 | +0.0% |
| HS 293299 - Heterocyclic compounds: with oxygen hetero-atom(s) only, no lactones or unfused furan rings (hydrogenated or not) in the structure, other than isosafrole, 1-(1,3-benzodiaxol-5-yl) propan-2-one, piperonal, safrole, tetrahydrocannabinols (all isomers) | $2.4B | $4.9M | $2.0B | +1.8% | 1 | +0.2% |
| HS 382319 - Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids) | $1.3B | $9.2M | $1.9B | +41.8% | 1 | +0.7% |
| HS 290122 - Acyclic hydrocarbons: unsaturated, propene (propylene) | $1.6B | $1.3M | $1.8B | -2.6% | 1 | +0.1% |
| HS 370790 - Photographic goods: chemical preparations other than sensitised emulsions, put up in measured portions or put up for retail sale in a form ready for use | $2.2B | $1.1M | $1.8B | +21.5% | 1 | +0.0% |
| HS 284390 - Inorganic or organic compounds: of precious metals (excluding gold and silver), whether or not chemically defined, amalgams of precious metals | $892.9M | $2.1K | $1.7B | +21.2% | 1 | +0.0% |
| HS 284690 - Compounds, inorganic or organic (excluding cerium), of rare-earth metals, of yttrium, scandium or of mixtures of these metals | $1.4B | $15.1M | $1.5B | +29.6% | 1 | +1.1% |
| HS 310420 - Fertilizers, mineral or chemical: potassic, potassium chloride | $3.3B | $14.6 | $1.4B | -42.7% | 1 | +0.0% |
| HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $1.2B | $105.7K | $1.4B | +62.8% | 1 | +0.0% |
| HS 310530 - Fertilizers, mineral or chemical: diammonium hydrogenorthophosphate (diammonium phosphate) | $2.7B | $3.0M | $1.3B | +16.6% | 1 | +0.1% |
| HS 290919 - Ethers: acyclic, and their halogenated, sulphonated, nitrated or nitrosated derivatives, other than diethyl ether | $2.0B | $1.6M | $1.3B | +438.5% | 1 | +0.1% |
| HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $875.7M | $12.7K | $1.3B | +0.5% | 1 | +0.0% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $1.8B | $34.5K | $1.2B | +15.8% | 1 | +0.0% |
| HS 321590 - Ink: writing, drawing and other inks, n.e.c. in heading no. 3215, whether or not concentrated or solid | $674.3M | $1.0K | $1.1B | +33.8% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $82.9B calculated opportunity across 14 products.
- China (CHN): $45.7B calculated opportunity across 17 products.
- Switzerland, Liechtenstein (CHE): $36.6B calculated opportunity across 4 products.
- Germany (DEU): $25.8B calculated opportunity across 8 products.
- Belgium (BEL): $16.1B calculated opportunity across 3 products.
- Slovenia (SVN): $12.9B calculated opportunity across 2 products.
- Netherlands (NLD): $10.5B calculated opportunity across 2 products.
- Republic of Korea (KOR): $9.3B calculated opportunity across 5 products.
- United Kingdom (GBR): $9.2B calculated opportunity across 4 products.
- Canada (CAN): $8.3B calculated opportunity across 4 products.
- France (FRA): $8.2B calculated opportunity across 4 products.
- Mexico (MEX): $6.9B calculated opportunity across 3 products.

## Growth stars

- HS 290919: +438.5% average CAGR, $1.3B calculated opportunity.
- HS 290531: +213.5% average CAGR, $2.2B calculated opportunity.
- HS 284190: +181.0% average CAGR, $5.6B calculated opportunity.
- HS 300215: +88.3% average CAGR, $41.2B calculated opportunity.
- HS 300212: +82.2% average CAGR, $16.1B calculated opportunity.
- HS 293499: +67.5% average CAGR, $7.4B calculated opportunity.
- HS 340220: +62.8% average CAGR, $1.4B calculated opportunity.
- HS 381800: +54.7% average CAGR, $3.2B calculated opportunity.
- HS 382200: +44.0% average CAGR, $6.3B calculated opportunity.
- HS 382319: +41.8% average CAGR, $1.9B calculated opportunity.

## Diversification opportunities

- HS 300490: 21 buyer markets, $115.1B calculated opportunity.
- HS 382499: 8 buyer markets, $16.7B calculated opportunity.
- HS 300439: 7 buyer markets, $12.4B calculated opportunity.
- HS 300212: 6 buyer markets, $16.1B calculated opportunity.
- HS 300215: 5 buyer markets, $41.2B calculated opportunity.
- HS 300220: 4 buyer markets, $18.0B calculated opportunity.
- HS 330210: 3 buyer markets, $10.7B calculated opportunity.
- HS 330499: 3 buyer markets, $6.9B calculated opportunity.
- HS 382200: 3 buyer markets, $6.3B calculated opportunity.
- HS 293499: 2 buyer markets, $7.4B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.